Back to CGEM
Lynx1 Capital Management LP → CGEM
Lynx1 Capital Management LP CGEM Position History
Cullinan Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$137.6M
Q3 2026
Peak value
$163.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $92.8M |
| Q1 2026 | $127.4M |
| Q2 2026 | $163.2M |
| Q2 2026 | $163.2M |
| Q3 2026 | $137.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $137.6M | 8.96M | — | — |
| Q2 2026 | $163.2M | 8.96M | — | — |
| Q2 2026 | $163.2M | 8.96M | — | — |
| Q1 2026 | $127.4M | 8.96M | — | — |
| Q4 2025 | $92.8M | 8.96M | — | — |
Other funds holding CGEM
$177.2M
$149.2M
$108.7M
$104.7M
$88.3M
$81.7M
$79.2M